… However, our results showed a much higher antibody response than reported in REACT-2,
especially in older people, despite studying the same UK population. These differences …

… ), the novel viral pathogen that causes coronavirus disease 2019 (COVID-19) in humans, …
of the human antibody response to SARS-CoV-2 infection is vitally important to inform vaccine …

… Here, we characterize the BNT162b2 vaccine-induced antibody responses among a …
vaccinated first in Finland, received two doses of COVID-19 vaccine with three weeks interval. …

… who developed a positive antibody response to the anti-S antibody are reported with point
… estimate the antibody response to a two-dose series of SARS-CoV-2 mRNA vaccines with or …

… to neutralizing antibodies in the presence of all SARS-CoV-2 … the neutralizing antibody titers
against SARS-CoV-2 variants … We realized that, although different, the antibody response …

… Whether enhanced vaccine-induced antibody responses among previously … vaccines
remains to be seen. In the meantime, our findings provide a rationale for serology-based vaccine …

… administered vaccine 7,8 . To this end, we evaluated SARS-CoV-2-specific antibody responses
after the first and second doses of the BNT162b2 (Pfizer–BioNTech) mRNA vaccine in a …

… Individuals with a previous COVID-19 symptomatic disease or a SARS-CoV-2 asymptomatic
… measuring SARS-CoV-2 antibody responses soon before the second dose of vaccine and …

… study assessing COVID-19 vaccine immune responses in lymphoid malignancies [NCT04858568]),
we report antibody levels before vaccination and 2 weeks after the first dose or 2–4 …

… response to 2 doses of mRNA SARS-CoV-2 vaccine among … antibody responses after the
second dose, although participants without a response after dose 1 had generally low antibody …